FHCLX — Select Health Care Portfolio
Data updated: 2026-07-24
FHCLX — Select Health Care Portfolio. United States Large Cap Blend / Core Health Care Equity · $5.78B AUM. Holdings, fees, performance and SEC filings.
FHCLX Fund Overview
FHCLX — Select Health Care Portfolio is a US mutual fund managed by Fidelity Select Portfolios, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Fidelity Select Portfolios
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $5.78B
- Ticker: FHCLX
- SEC CIK: 0000320351
- SEC series ID: S000007466
- Share class ID: C000272243
FHCLX Investment Objective and Strategy
Select Health Care Portfolio describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Fidelity Select Portfolios.
Investment objective
Health Care Portfolio seeks capital appreciation.
Principal investment strategy
Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are committed to, derived from, or related to the designated business activity or activities, or (ii) whether a third party has given the company an industry or sector classification consistent with the designated business activity or activities.
Whether a company is principally engaged in the designated business activity or activities can be determined under any of these factors. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in the fund's 80% policy, consistent with the fund's investment policies and limitations with respect to investments in derivatives. Normally investing primarily in common stocks. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
FHCLX Holdings
Top 10 holdings of Select Health Care Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| ELI LILLY and CO | 8.03% |
| Danaher Corp. | 6.89% |
| JOHNSON and JOHNSON | 4.91% |
| Thermo Fisher Scientific, Inc. | 4.33% |
| Unitedhealth Group, Inc. | 3.49% |
| Alnylam Pharmaceuticals, Inc. | 2.40% |
| Gilead Sciences, Inc. | 2.21% |
| Boston Scientific Corp. | 2.17% |
| Ascendis Pharma A/s | 2.17% |
| Fidelity Revere Street Trust | 2.17% |
FHCLX Portfolio Allocation
Asset-class allocation of Select Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 2.4% |
| Fixed Income | 0.1% |
FHCLX Performance
Total returns for FHCLX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.9% |
| 1 year | 19.5% |
| 3 years (annualised) | 6.8% |
| 5 years (annualised) | 2.5% |
FHCLX Risk Information
Risk metrics for FHCLX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 13.5%
FHCLX Costs and Fees
FHCLX costs about $91 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.91%
- Gross expense ratio: 0.91%
- Portfolio turnover: 69%
- Brokerage commissions: 3.32 bps of average net assets (SEC N-CEN)
FHCLX Cashflows
Over the 12 months to 2026-05, Select Health Care Portfolio had net outflows of $51.64M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$78.72M |
| 2026-04 | $490.90M |
| 2026-03 | −$49.55M |
| 2026-02 | −$64.74M |
| 2026-01 | −$87.83M |
| 2025-12 | $321.26M |
FHCLX Debt Constituents
Largest debt holdings of Select Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Kardium Inc/us | 0.08% |
| Wugen, Inc. | 0.04% |
| Galvanize Therapeutics | 0.02% |
FHCLX Prospectus and SEC Filings
Official Select Health Care Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-24
- Prospectus (485BPOS) — filed 2026-03-05
- Prospectus (485BPOS) — filed 2025-04-24
- Portfolio holdings (N-PORT) — filed 2026-07-24
- Portfolio holdings (N-PORT) — filed 2026-04-24
- Portfolio holdings (N-PORT) — filed 2026-01-23
- Annual census (N-CEN) — filed 2026-05-12
- Annual census (N-CEN) — filed 2025-05-13
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.